[Aminoglutethimide in the treatment of advanced prostatic cancer]
- PMID: 4039084
[Aminoglutethimide in the treatment of advanced prostatic cancer]
Abstract
A total of ten previously castrated men with stage D carcinoma received 1000 mg aminoglutethimide and 50 mg/die cortisoneacetate. The patients were evaluated using the criteria of the National Prostate Cancer Project. No patients showed objective response, three patients had reduction of bone pain and subjective improvement. Pretreatment testosterone, prolactine and estradiol levels were measured. Three patients had a statistically significant elevation of testosterone levels.
Similar articles
-
Pretreatment hormone levels in prostatic cancer.Scand J Urol Nephrol Suppl. 1988;110:137-43. Scand J Urol Nephrol Suppl. 1988. PMID: 3187401
-
[The effect of aminoglutethimide on steroid synthesis of the adrenal gland and its use in prostate cancer].Helv Chir Acta. 1989 Aug;56(3):347-50. Helv Chir Acta. 1989. PMID: 2807964 German.
-
Clinical and biochemical effect of aminoglutethimide in the treatment of advanced prostatic carcinoma.J Urol. 1983 Jan;129(1):51-5. doi: 10.1016/s0022-5347(17)51916-3. J Urol. 1983. PMID: 6827685
-
[New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].J Pharmacol. 1983;14 Suppl 3:117-35. J Pharmacol. 1983. PMID: 6423907 Review. French.
-
Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.J Clin Invest. 1980 Mar;65(3):602-12. doi: 10.1172/JCI109705. J Clin Invest. 1980. PMID: 6986409 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical